title: Soybean isoflavone alleviates β-amyloid 1-42 induced inflammatory response to improve learning and memory ability by down regulation of Toll-like receptor 4 expression and nuclear factor-κB activity in rats.
abstract: β-amyloid 1-42 (Aβ1-42)-induced learning and memory impairment in rats is believed to be associated with inflammation. Cytokine production is a key pathologic event in the progression of inflammatory processes. In this rat study, soybean isoflavones (SIF) was used to investigate it's protective effects on inflammation caused by β-amyloid 1-42 (Aβ1-42), which is associated with learning and memory impairment in Alzheimer disease. We characterized the learning and memory ability. cytokine profiles of circulating interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) in the serum and the expression of Toll like receptor4 (TLR4) and nuclear factor-κB p65 (NF-κB p65) mRNA and protein in the brain tissue following intracerebroventricular administration of Aβ1-42 by miniosmotic pump for 14 days. The results showed that functional deficits of learning and memory in SIF treatment groups were significantly improved compared to the control group without SIF treatment in water maze test. The serum IL-1β and TNF-α level were significantly increased, and the expressions of TLR4 and NF-κB p65 mRNA and protein in the brain were up-regulated, indicating inflammation response was initiated following administration of Aβ1-42. After intragastric pre-treatment with SIF, inflammatory cytokines was significantly reduced and also SIF reversed the Aβ1-42 induced up-regulation of TLR4 and NF-κB p65 mRNA and protein expression in the brain and expression of NF-κB p65 in nuclei. These results suggested that SIF reduced the cytokine cascade and inflammatory response induced by Aβ1-42 which could result in the improvement of spatial learning and memory ability impairment in the rats.
authors.affiliation: Department of Nutrition & Food Hygiene, School of Public Health and Family Medicine, Capital Medical University, No. 10 Xitoutiao, You An Men Wai, Beijing 100069, PR China.
authors.forename: B J
authors.initials: BJ
authors.lastname: Ding
authors.forename: W W
authors.initials: WW
authors.lastname: Ma
authors.forename: L L
authors.initials: LL
authors.lastname: He
authors.forename: X
authors.initials: X
authors.lastname: Zhou
authors.forename: L H
authors.initials: LH
authors.lastname: Yuan
authors.forename: H L
authors.initials: HL
authors.lastname: Yu
authors.forename: J F
authors.initials: JF
authors.lastname: Feng
authors.forename: R
authors.initials: R
authors.lastname: Xiao
mesh_terms: D016229:Amyloid beta-Peptides / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000033:anatomy & histology / Q000187:drug effects / Q000502:physiology; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy; D053583:Interleukin-1beta / Q000097:blood; D007529:Isoflavones / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D018782:Maze Learning / Q000187:drug effects*; D008568:Memory / Q000187:drug effects*; D010446:Peptide Fragments / Q000494:pharmacology*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D013025:Glycine max / Q000737:chemistry; D051197:Toll-Like Receptor 4 / Q000235:genetics / Q000378:metabolism*; D051996:Transcription Factor RelA / Q000235:genetics / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
chemical_list: D016229:Amyloid beta-Peptides; D053583:Interleukin-1beta; D007529:Isoflavones; D010446:Peptide Fragments; C498145:Rela protein, rat; D051197:Toll-Like Receptor 4; D051996:Transcription Factor RelA; D014409:Tumor Necrosis Factor-alpha; C075222:amyloid beta-protein (1-42)